Icici Securities Inc

Rediff.com » News » Icici Securities Inc

News for Icici Securities Inc

Business

Q3 result preview: US, India to aid revenue growth for Pharma Inc

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

'We prefer stocks likely to gain from strong domestic growth potential'

'We like certain stocks from banking, insurance, retail, hospitals and capital goods.''Though some of these stocks may seem expensive, they will compound well over the long term, thus justifying......

India Inc net profit share in GDP now just shy of 5% after robust Q2

India Inc’s net profit as a percentage of the country's gross domestic product (GDP) is just shy of reaching 5 per cent, bolstered by strong earnings growth in the second quarter of 2023-24.......

India Inc may see over 22% profit jump in Q1; revenue growth may disappoint

Brokerages expect Nifty50 companies to have cumulatively witnessed strong double-digit growth in their earnings in the first quarter of FY24 (Q1FY24). Illustration: Dominic Xavier/Rediff.com This......

India Inc's profit-to-GDP ratio dips slightly in FY23; financial pie up

Corporate India’s net profit as a percentage of gross domestic product (GDP) dipped in the 2022-23 financial year (FY23) -- after rebounding sharply in FY22 -- amid a decline in global......

Rediff News

Icici Securities Inc

News for Icici Securities Inc

Q3 result preview: US, India to aid revenue growth for Pharma Inc

'We prefer stocks likely to gain from strong domestic growth potential'

India Inc net profit share in GDP now just shy of 5% after robust Q2

India Inc may see over 22% profit jump in Q1; revenue growth may disappoint

India Inc's profit-to-GDP ratio dips slightly in FY23; financial pie up

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS